The Influence of Blood on In Vivo Adenovirus Bio-distribution and Transduction
Intravascular delivery of adenovirus (Ad) vectors is being developed for liver-directed gene therapy for targeting disseminated disease in cancer therapeutics and for targeting non-hepatic tissues and organs through vector engineering strategies. The utility of Ad vectors is not limited to serotype...
Gespeichert in:
| Veröffentlicht in: | Molecular therapy 2007-08, Vol.15 (8), p.1410-1416 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1416 |
|---|---|
| container_issue | 8 |
| container_start_page | 1410 |
| container_title | Molecular therapy |
| container_volume | 15 |
| creator | Baker, Andrew H Mcvey, John H Waddington, Simon N Di Paolo, Nelson C Shayakhmetov, Dmitry M |
| description | Intravascular delivery of adenovirus (Ad) vectors is being developed for liver-directed gene therapy for targeting disseminated disease in cancer therapeutics and for targeting non-hepatic tissues and organs through vector engineering strategies. The utility of Ad vectors is not limited to serotype 5 (Ad5), and many alternate human serotypes and non-human serotypes of Ad are currently being investigated. Critical to intravascular delivery of Ad is the interaction of the virus with host blood cells and plasma proteins, because immediate contact is observed following injection. Although incompletely understood, recent studies suggest that these interactions are critical in dictating the particle bio-distribution and resulting transduction properties of Ad in vivo. For example, plasma proteins—in particular, vitamin K–dependent coagulation zymogens—are able to directly bind to Ad, and “bridge” the virus to receptors in the liver. Unraveling and characterizing these mechanisms will be of fundamental importance both for understanding basic Ad biology in vivo and for refinement and optimization of Ad vectors for human gene therapy. |
| doi_str_mv | 10.1038/sj.mt.6300206 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1792609024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525001616324340</els_id><sourcerecordid>4073003521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-c4f2a3d5d0bd456fea077743920f9f5bb75e9115c1ac73fd8ee3e20a5c45b9c13</originalsourceid><addsrcrecordid>eNp1kM9PwyAUx4nRuDk9ejVNPHdCW2Act8UfSxa9TK-EwiPSbGVCu8T_XpY1evIC77188oX3QeiW4CnB5ewhNtNdN2UlxgVmZ2hMaEHz1FTnvzVhI3QVY5MqQgW7RCPCKaYVE2P0uvmEbNXabQ-thszbbLH13mS-TdPswx18NjfQ-oMLfcwWzufGxS64uu9cYlRrsk1QbTS9Pg6u0YVV2wg3wz1B70-Pm-VLvn57Xi3n61xXmHXptIUqDTW4NhVlFhTmnFelKLAVltY1pyDSZzVRmpfWzABKKLCiuqK10KScoPtT7j74rx5iJxvfhzY9KQkXBcMiGUhUfqJ08DEGsHIf3E6Fb0mwPNqTsZG7Tg72En83pPb1DswfPehKAD8BkHY7OAgyancUZ1wA3Unj3T_RPxMqfck</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1792609024</pqid></control><display><type>article</type><title>The Influence of Blood on In Vivo Adenovirus Bio-distribution and Transduction</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Baker, Andrew H ; Mcvey, John H ; Waddington, Simon N ; Di Paolo, Nelson C ; Shayakhmetov, Dmitry M</creator><creatorcontrib>Baker, Andrew H ; Mcvey, John H ; Waddington, Simon N ; Di Paolo, Nelson C ; Shayakhmetov, Dmitry M</creatorcontrib><description>Intravascular delivery of adenovirus (Ad) vectors is being developed for liver-directed gene therapy for targeting disseminated disease in cancer therapeutics and for targeting non-hepatic tissues and organs through vector engineering strategies. The utility of Ad vectors is not limited to serotype 5 (Ad5), and many alternate human serotypes and non-human serotypes of Ad are currently being investigated. Critical to intravascular delivery of Ad is the interaction of the virus with host blood cells and plasma proteins, because immediate contact is observed following injection. Although incompletely understood, recent studies suggest that these interactions are critical in dictating the particle bio-distribution and resulting transduction properties of Ad in vivo. For example, plasma proteins—in particular, vitamin K–dependent coagulation zymogens—are able to directly bind to Ad, and “bridge” the virus to receptors in the liver. Unraveling and characterizing these mechanisms will be of fundamental importance both for understanding basic Ad biology in vivo and for refinement and optimization of Ad vectors for human gene therapy.</description><identifier>ISSN: 1525-0016</identifier><identifier>EISSN: 1525-0024</identifier><identifier>DOI: 10.1038/sj.mt.6300206</identifier><identifier>PMID: 17505469</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenoviridae - physiology ; Adenoviruses ; Animals ; Antibodies ; Antigens ; Blood ; Blood Cells - virology ; Blood Proteins - genetics ; Blood Proteins - metabolism ; Cancer ; Drug dosages ; Enzymes ; Gene therapy ; Genetic Therapy - methods ; Humans ; Infections ; Liver ; Neutrophils ; Tissue Distribution ; Toxicity ; Transduction, Genetic - methods ; Vectors (Biology)</subject><ispartof>Molecular therapy, 2007-08, Vol.15 (8), p.1410-1416</ispartof><rights>2007 The American Society of Gene Therapy</rights><rights>Copyright Nature Publishing Group Aug 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-c4f2a3d5d0bd456fea077743920f9f5bb75e9115c1ac73fd8ee3e20a5c45b9c13</citedby><cites>FETCH-LOGICAL-c406t-c4f2a3d5d0bd456fea077743920f9f5bb75e9115c1ac73fd8ee3e20a5c45b9c13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17505469$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baker, Andrew H</creatorcontrib><creatorcontrib>Mcvey, John H</creatorcontrib><creatorcontrib>Waddington, Simon N</creatorcontrib><creatorcontrib>Di Paolo, Nelson C</creatorcontrib><creatorcontrib>Shayakhmetov, Dmitry M</creatorcontrib><title>The Influence of Blood on In Vivo Adenovirus Bio-distribution and Transduction</title><title>Molecular therapy</title><addtitle>Mol Ther</addtitle><description>Intravascular delivery of adenovirus (Ad) vectors is being developed for liver-directed gene therapy for targeting disseminated disease in cancer therapeutics and for targeting non-hepatic tissues and organs through vector engineering strategies. The utility of Ad vectors is not limited to serotype 5 (Ad5), and many alternate human serotypes and non-human serotypes of Ad are currently being investigated. Critical to intravascular delivery of Ad is the interaction of the virus with host blood cells and plasma proteins, because immediate contact is observed following injection. Although incompletely understood, recent studies suggest that these interactions are critical in dictating the particle bio-distribution and resulting transduction properties of Ad in vivo. For example, plasma proteins—in particular, vitamin K–dependent coagulation zymogens—are able to directly bind to Ad, and “bridge” the virus to receptors in the liver. Unraveling and characterizing these mechanisms will be of fundamental importance both for understanding basic Ad biology in vivo and for refinement and optimization of Ad vectors for human gene therapy.</description><subject>Adenoviridae - physiology</subject><subject>Adenoviruses</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Blood</subject><subject>Blood Cells - virology</subject><subject>Blood Proteins - genetics</subject><subject>Blood Proteins - metabolism</subject><subject>Cancer</subject><subject>Drug dosages</subject><subject>Enzymes</subject><subject>Gene therapy</subject><subject>Genetic Therapy - methods</subject><subject>Humans</subject><subject>Infections</subject><subject>Liver</subject><subject>Neutrophils</subject><subject>Tissue Distribution</subject><subject>Toxicity</subject><subject>Transduction, Genetic - methods</subject><subject>Vectors (Biology)</subject><issn>1525-0016</issn><issn>1525-0024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kM9PwyAUx4nRuDk9ejVNPHdCW2Act8UfSxa9TK-EwiPSbGVCu8T_XpY1evIC77188oX3QeiW4CnB5ewhNtNdN2UlxgVmZ2hMaEHz1FTnvzVhI3QVY5MqQgW7RCPCKaYVE2P0uvmEbNXabQ-thszbbLH13mS-TdPswx18NjfQ-oMLfcwWzufGxS64uu9cYlRrsk1QbTS9Pg6u0YVV2wg3wz1B70-Pm-VLvn57Xi3n61xXmHXptIUqDTW4NhVlFhTmnFelKLAVltY1pyDSZzVRmpfWzABKKLCiuqK10KScoPtT7j74rx5iJxvfhzY9KQkXBcMiGUhUfqJ08DEGsHIf3E6Fb0mwPNqTsZG7Tg72En83pPb1DswfPehKAD8BkHY7OAgyancUZ1wA3Unj3T_RPxMqfck</recordid><startdate>20070801</startdate><enddate>20070801</enddate><creator>Baker, Andrew H</creator><creator>Mcvey, John H</creator><creator>Waddington, Simon N</creator><creator>Di Paolo, Nelson C</creator><creator>Shayakhmetov, Dmitry M</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20070801</creationdate><title>The Influence of Blood on In Vivo Adenovirus Bio-distribution and Transduction</title><author>Baker, Andrew H ; Mcvey, John H ; Waddington, Simon N ; Di Paolo, Nelson C ; Shayakhmetov, Dmitry M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-c4f2a3d5d0bd456fea077743920f9f5bb75e9115c1ac73fd8ee3e20a5c45b9c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adenoviridae - physiology</topic><topic>Adenoviruses</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Blood</topic><topic>Blood Cells - virology</topic><topic>Blood Proteins - genetics</topic><topic>Blood Proteins - metabolism</topic><topic>Cancer</topic><topic>Drug dosages</topic><topic>Enzymes</topic><topic>Gene therapy</topic><topic>Genetic Therapy - methods</topic><topic>Humans</topic><topic>Infections</topic><topic>Liver</topic><topic>Neutrophils</topic><topic>Tissue Distribution</topic><topic>Toxicity</topic><topic>Transduction, Genetic - methods</topic><topic>Vectors (Biology)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baker, Andrew H</creatorcontrib><creatorcontrib>Mcvey, John H</creatorcontrib><creatorcontrib>Waddington, Simon N</creatorcontrib><creatorcontrib>Di Paolo, Nelson C</creatorcontrib><creatorcontrib>Shayakhmetov, Dmitry M</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Molecular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baker, Andrew H</au><au>Mcvey, John H</au><au>Waddington, Simon N</au><au>Di Paolo, Nelson C</au><au>Shayakhmetov, Dmitry M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Influence of Blood on In Vivo Adenovirus Bio-distribution and Transduction</atitle><jtitle>Molecular therapy</jtitle><addtitle>Mol Ther</addtitle><date>2007-08-01</date><risdate>2007</risdate><volume>15</volume><issue>8</issue><spage>1410</spage><epage>1416</epage><pages>1410-1416</pages><issn>1525-0016</issn><eissn>1525-0024</eissn><abstract>Intravascular delivery of adenovirus (Ad) vectors is being developed for liver-directed gene therapy for targeting disseminated disease in cancer therapeutics and for targeting non-hepatic tissues and organs through vector engineering strategies. The utility of Ad vectors is not limited to serotype 5 (Ad5), and many alternate human serotypes and non-human serotypes of Ad are currently being investigated. Critical to intravascular delivery of Ad is the interaction of the virus with host blood cells and plasma proteins, because immediate contact is observed following injection. Although incompletely understood, recent studies suggest that these interactions are critical in dictating the particle bio-distribution and resulting transduction properties of Ad in vivo. For example, plasma proteins—in particular, vitamin K–dependent coagulation zymogens—are able to directly bind to Ad, and “bridge” the virus to receptors in the liver. Unraveling and characterizing these mechanisms will be of fundamental importance both for understanding basic Ad biology in vivo and for refinement and optimization of Ad vectors for human gene therapy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>17505469</pmid><doi>10.1038/sj.mt.6300206</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1525-0016 |
| ispartof | Molecular therapy, 2007-08, Vol.15 (8), p.1410-1416 |
| issn | 1525-0016 1525-0024 |
| language | eng |
| recordid | cdi_proquest_journals_1792609024 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Adenoviridae - physiology Adenoviruses Animals Antibodies Antigens Blood Blood Cells - virology Blood Proteins - genetics Blood Proteins - metabolism Cancer Drug dosages Enzymes Gene therapy Genetic Therapy - methods Humans Infections Liver Neutrophils Tissue Distribution Toxicity Transduction, Genetic - methods Vectors (Biology) |
| title | The Influence of Blood on In Vivo Adenovirus Bio-distribution and Transduction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T09%3A55%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Influence%20of%20Blood%20on%20In%20Vivo%20Adenovirus%20Bio-distribution%20and%20Transduction&rft.jtitle=Molecular%20therapy&rft.au=Baker,%20Andrew%20H&rft.date=2007-08-01&rft.volume=15&rft.issue=8&rft.spage=1410&rft.epage=1416&rft.pages=1410-1416&rft.issn=1525-0016&rft.eissn=1525-0024&rft_id=info:doi/10.1038/sj.mt.6300206&rft_dat=%3Cproquest_cross%3E4073003521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1792609024&rft_id=info:pmid/17505469&rft_els_id=S1525001616324340&rfr_iscdi=true |